SEC Form 4 · accession 0001013606-19-000018
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeremy B. Hayden
Officer — General Counsel
Period of report
Dec 30, 2018
Accepted (ET)
Jan 2, 2019 · 8:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF1 | $0.7445 | Dec 30, 2018 | A | 216,449 | A | Dec 30, 2019 | Dec 30, 2028 | Common Stock | 216,449 | 216,449 | D |
Explanation of responses
- F1100% of the option award shall vest on December 30, 2019.